Drugs
Drug safety and effectiveness, pharmaceutical pricing and policy, antibiotics and antimicrobial resistance, and more
Drugs Headlines
Explore the latest public health research and insights about drugs.
HPM Faculty Member Jeromie Ballreich, PhD, MHS, testifies before House Ways and Means Committee
On Tuesday, February 6, Jeromie Ballreich, PhD, testified before the House Ways and Means Committee, addressing the critical issue of chronic drug shortages in the United States. He highlighted the complexity of factors contributing to shortages and proposed four policy solution sets for Congress to consider.
Drugs Faculty Experts
Looking for prominent public health experts in the field of drugs? They’re here at the Bloomberg School of Public Health.
Joshua Sharfstein, MD, works to develop and promote public health strategies, healthcare payment approaches, and regulatory policies that advance health and equity.
G. Caleb Alexander, MD, MS, is a practicing internist and epidemiologist focused on maximizing the use, safety, and effectiveness of prescription medicines.
Gerard Anderson, PhD, works with policymakers to control health care spending.
Aditi Sen, PhD, MA, is a health economist working to design and implement payment and delivery systems that improve quality of and access to care for all Americans.